Compare Medtronic PLC (MDT) vs Invesco Preferred ETF (PGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Invesco Preferred ETF — how do they compare? Medtronic PLC trades at $82.67 (market cap $106.61B), while Invesco Preferred ETF trades at $10.8. The key difference: Medtronic PLC pays a 3.46% dividend while Invesco Preferred ETF pays none, and Medtronic PLC is trading nearer its 52-week high, Invesco Preferred ETF nearer its low. Which is the better fit depends on your goals.
| MDT | PGX | |
|---|---|---|
Market Cap | $106.61B | — |
Sector | Health | — |
52-Week High | $105.35 | $11.87 |
52-Week Low | $73.75 | $10.81 |
Enterprise Value | $125.36B | — |
Dividend Yield | 3.46% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
PGX trades at $10.81, down 0.46% on the day, with a bearish technical outlook from moving averages and neutral oscillators. The stock shows uniform support and resistance at $11. Recent corporate actions include upcoming dividends of $0.06 and $0.05 scheduled for July and June 2026, respectively. Financial ratios such as P/E, P/S, and ROE are not provided, limiting fundamental assessment.
The outlook for PGX is cautious due to bearish technical signals and negative media sentiment highlighting poor returns and limited downside protection. Investment opportunities may arise from dividend income, but risks include market volatility and structural subordination issues. Investors should weigh the income potential against significant downside risks in volatile conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Invesco Preferred ETF
The fund generally will invest at least 80% of its total assets in the components of the index. Strictly in accordance with its guidelines and mandated procedures, ICE Data Indices, LLC selects securities for the index, which is a market capitalization-weighted index designed to measure the performance of the fixed rate US dollar-denominated preferred securities market.
Read more on PGX →
